Cargando…

Current and Future Biomarkers in Multiple Sclerosis

Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of effective treatment for the progressive form of MS, partly due to insensitive readout for neurodegeneration. The recent development of sensitive assays for neurofilament light chain (NfL) has made it a poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jennifer, Hamade, Maysa, Wu, Qi, Wang, Qin, Axtell, Robert, Giri, Shailendra, Mao-Draayer, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180348/ https://www.ncbi.nlm.nih.gov/pubmed/35682558 http://dx.doi.org/10.3390/ijms23115877

Ejemplares similares

Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis
por: Soltys, John, et al.
Publicado: (2017)

Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis
por: Wu, Qi, et al.
Publicado: (2021)

Dual Role of B Cells in Multiple Sclerosis
por: Kumar, Gaurav, et al.
Publicado: (2023)

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets
por: Lundy, Steven K., et al.
Publicado: (2016)

20680 Characterization of Clinical and Immunological Laboratory Features in Multiple Sclerosis Patients with COVID-19
por: Ali, Ahya S, et al.
Publicado: (2021)

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse
por: Mills, Elizabeth A., et al.
Publicado: (2017)

Current and Future Therapies for Multiple Sclerosis
por: Minagar, Alireza
Publicado: (2013)

Familial multiple sclerosis in patients with Von Hippel-Lindau disease
por: Nath, Samir R., et al.
Publicado: (2022)

Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Quinn, James L., et al.
Publicado: (2018)

Biomarkers of multiple sclerosis: current findings
por: Harris, Violaine K, et al.
Publicado: (2017)

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives
por: Coyle, Patricia K.
Publicado: (2017)

Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird’s Eye View
por: Mills, Elizabeth A., et al.
Publicado: (2018)

Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration
por: Thakolwiboon, Smathorn, et al.
Publicado: (2023)

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis
por: Mills, Elizabeth A., et al.
Publicado: (2018)

An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview
por: Zahoor, Insha, et al.
Publicado: (2021)

Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies
por: Ali, Ahya, et al.
Publicado: (2021)

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
por: Harris, Violaine K., et al.
Publicado: (2014)

The Role of B Cells in Primary Progressive Multiple Sclerosis
por: Holloman, Jameson P., et al.
Publicado: (2021)

Toward Precision Phenotyping of Multiple Sclerosis
por: Pitt, David, et al.
Publicado: (2022)

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021)

Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies
por: Yeh, E Ann
Publicado: (2010)

Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions
por: Maxwell, Dain L., et al.
Publicado: (2023)

The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer
por: Shi, Ying, et al.
Publicado: (2023)

A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods
por: Lane, Giulia I., et al.
Publicado: (2020)

Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathway
por: Wang, Qin, et al.
Publicado: (2015)

Molecular biomarkers in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Digital Biomarkers in Multiple Sclerosis
por: Dillenseger, Anja, et al.
Publicado: (2021)

Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives
por: Chu, Fengna, et al.
Publicado: (2018)

Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
por: Tryfonos, Christina, et al.
Publicado: (2019)

Protein biomarkers in multiple sclerosis
por: Kim, Jun-Soon
Publicado: (2023)

Current concepts in multiple sclerosis therapy
por: Sedal, Leslie, et al.
Publicado: (2017)

Pediatric multiple sclerosis: current perspectives on health behaviors
por: Sikes, Elizabeth Morghen, et al.
Publicado: (2018)

Pedometers and Accelerometers in Multiple Sclerosis: Current and New Applications
por: Sasaki, Jeffer Eidi, et al.
Publicado: (2022)

Monoclonal Antibodies in Multiple Sclerosis: Present and Future
por: Voge, Natalia V., et al.
Publicado: (2019)

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis
por: Fadul, Camilo E., et al.
Publicado: (2021)

Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
por: Park, Jeongho, et al.
Publicado: (2019)

Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
por: Park, Jeongho, et al.
Publicado: (2019)

Multiple Sclerosis and Pregnancy: Current Considerations
por: Buraga, Ioan, et al.
Publicado: (2014)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

Current Advances in Pediatric Onset Multiple Sclerosis
por: Fisher, Kristen S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a5bg5uu5fg5iiqgl0ks2m8uudo